Identifying genes that affect metabolic diseases and insulin resistance

Credentialing metabolic disease genes through human genetics and functional genomics

NIH-funded research VA San Diego Healthcare System · NIH-11063124

This study is looking at how our genes might affect insulin resistance, which can lead to type 2 diabetes, and it's especially focused on helping veterans and people of African descent by finding new treatment options.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA San Diego Healthcare System NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-11063124 on NIH RePORTER

What this research studies

This research investigates the genetic factors that contribute to insulin resistance, a key driver of type 2 diabetes and other serious health conditions. By using advanced genomic techniques, the study aims to identify specific genes that can be targeted for new treatments, particularly focusing on populations that have been underrepresented in previous research, such as individuals of African descent. The approach combines genetic analysis with functional studies to validate potential therapeutic targets, which could lead to more effective treatments for obesity-related metabolic diseases. The research is particularly relevant for veterans, who are disproportionately affected by these conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research include veterans, especially those of African ancestry, who are experiencing insulin resistance or related metabolic conditions.

Not a fit: Patients who do not have insulin resistance or related metabolic diseases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new, more effective treatments for insulin resistance and related metabolic diseases, improving health outcomes for many patients.

How similar studies have performed: Previous research has shown promise in identifying genetic factors related to metabolic diseases, but this study aims to address gaps in representation and understanding, making it a novel approach.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions adult onset diabetesAdult-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.